ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1653	National Cancer Institute	Html	en	Cancer Genetics Overview (PDQ®)–Health Professional Version	Expert-reviewed information summary in which the features of hereditary cancer and the structure and content of other PDQ cancer genetics summaries are described. The summary also contains an extensive list of genetics resources available online.	risk assessment 0.737084 germline genetic testing 0.616915 pathogenic germline variants 0.607786 genetics cancer risk 0.586595 germline testing 0.54014 individual PDQ summaries 0.545357 common genetic variants 0.594544 Founder pathogenic variants 0.555775 Cancer Genetics Risk 0.634713 tumor sequencing 0.540563 cancer risk counseling 0.587676 genetic risk 0.584149 health care providers 0.553143 genetic risk assessment 0.574763 family members 0.586643 pathogenic variant 0.712171 cancer predisposition genes 0.581734 cancer risk assessment 0.656292 BRCA1/BRCA2 pathogenic variants 0.580746 rare genetic variants 0.585466 familial cancer risk 0.606217 germline pathogenic variant 0.590911 specific pathogenic variant 0.581389 genetic cancer susceptibility 0.617626 genetic sequence testing 0.55336	breast cancer panel 0.575181 genetic counseling 0.75599 certain pathogenic variants 0.569596 cancer susceptibility genes 0.662603 multigene testing 0.554102 pathogenic variants 0.772898 term pathogenic variant 0.577821 genetic information 0.615701 predisposition genetic testing 0.569525 health care 0.629277 actionable genetic variants 0.56222 cancer susceptibility 0.729483 multigene tests 0.585492 Cancer genetic counseling 0.65952 breast cancer 0.623534 cancer predisposition multigene 0.547293 cancer susceptibility gene 0.552935 well-characterized cancer susceptibility 0.539905 genetic variants 0.628939 prostate cancer 0.563348 genetic testing 0.723596 family history 0.559221 cancer risk 0.746235 cancer 0.908258	CLICK HERE
1773	National Cancer Institute	Html	es	Trastornos del sueño (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las causas de los trastornos del sueño de las personas con cáncer y su manejo.	American Academy 0.62007 sleep disturbance 0.546203 Sateia MJ 0.426893 Sleep Disturbance Scale 0.434259 CdV Mejoras 0.428861 mg riesgo 0.50361 National Sleep Foundation 0.473914 Sleep Quality Index 0.466452 Simard S 0.452533 neglected problem 0.428741 sueño mor 0.943385 risk factors 0.426951 sleep-wake disturbances 0.458084 Sleep Disorders 0.45951 Oncol Nurs 0.45478 PDQ Delirium 0.436712 coordinación motriz 0.436956 sueño diario 0.570793 sleep disruption 0.458489 Insomnia Severity Index 0.446987 patients with 0.455594 Hirshkowitz M 0.42487 Pittsburgh Sleep Quality 0.464939 Insomnia Severity 0.454434 sueño frente 0.501612	Roscoe JA 0.426353 Oncol Nurs Forum 0.453234 Morin CM 0.426813 sueño categoría 0.493243 Care Cancer 0.439262 Palesh OG 0.427427 ECA Control 0.495325 Savard J 0.54747 Sleep Medicine review 0.435342 Mustian KM 0.426387 patients based 0.427546 Rochester Cancer Center-Community 0.462263 Clinical Oncology Program 0.450218 sleep regulation 0.427006 sueño nmor 0.697198 Clin Oncol 0.506515 Clin North Am 0.455007 estadio i–iii 0.467766 Center-Community Clinical Oncology 0.451231 psychological associations 0.42745 Cancer Center-Community Clinical 0.464249 Sleep Medicine 0.709305 Med Clin North 0.456379 Sleep Disorders Classification 0.439634	CLICK HERE
1908	National Cancer Institute	Html	es	Tratamiento de la leucemia mieloide aguda en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda en adultos.	linfocítica aguda 0.505572 leucemia promielocítica aguda 0.536157 siguientes procedimientos 0.505247 células madre 0.703397 leucemia mielógena aguda 0.512482 posibles factores 0.501447 siguientes aspectos 0.5019 leucemia aguda 0.511873 radiación quizás 0.505162 leucemia linfoblástica aguda 0.535526 LMA quizás 0.505703 hueso compacto 0.505434 neoplasias mieloides 0.501631 rayos x 0.501258 enlace drugs approved 0.505977 Acute Myeloid Leukemia 0.506164 célula madre mieloide 0.516071 cáncer.ampliar aspiración 0.501565 líquido cefalorraquídeo 0.511938	punción espinal.Ampliar 0.501523 National Cancer Institute 0.501258 leucemia granulocítica aguda 0.512402 Instituto Nacional 0.502137 célula madre linfoide 0.510737 PDQ Tratamiento 0.503456 sustancia química benceno 0.502803 leucemia mielógena 0.513696 médula espinal.ampliar quimioterapia 0.50588 leucemia mieloblástica aguda 0.512403 sistema nervioso central 0.50789 Physician Data Query 0.504454 madre mieloides 0.518606 siguientes situaciones 0.504197 células madre mieloides 0.508803 leucemia mieloide aguda 0.995372 célula madre 0.532153 blastocito mieloide 0.505386 siguientes sumarios 0.503116	CLICK HERE
1927	National Cancer Institute	Html	es	Tratamiento del linfoma de Hodgkin infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin infantil.	siguientes procedimientos 0.539535 células madre 0.949818 estadio iv 0.500925 adultos jóvenes 0.452563 órgano cercano.ampliar linfoma 0.561365 siguientes elementos 0.448931 sudores nocturnos 0.484622 faja ajustadora 0.430459 siguientes especialistas 0.43177 siguientes tipos 0.443725 vía oral 0.419326 rayos x 0.473568 Hodgkin Lymphoma 0.582459 abdomen).ampliar linfoma 0.535694 detecte.ampliar exploración 0.434601 enlace drugs approved 0.498183 escáner tep 0.492453 niño ayuda 0.424524 estadio iiies 0.760474 riesgo intermedio 0.462626 efectos tardíos 0.664689 estadio ie 0.575058 células anormales.ampliar aspiración 0.485872	PDQ Efectos tardíos 0.461638 National Cancer Institute 0.420283 sustancia quizás 0.427861 siguientes lugares 0.433237 siguientes riesgos 0.418851 Instituto Nacional 0.434896 PDQ Tratamiento 0.682769 estadio iie 0.500587 Hodgkin recién 0.557678 explorador tep 0.443167 estadio e 0.45134 nuevos tipos 0.421275 Physician Data Query 0.471298 posibles efectos 0.420063 infancia quizás 0.428464 estadio iiis 0.959473 ósea fabrica glóbulos 0.493208 pelvis.ampliar imágenes 0.420331 distinta intensidad 0.419212 almacena células 0.485736 siguientes pruebas 0.485604 siguientes estadios 0.440037	CLICK HERE
2987	National Cancer Institute	Html	en	Secondhand Smoke	When you smoke, it doesn't just affect you. And it's not just irritating to those around you, it's deadly.	feet 0.409991 dangers 0.420271 Lung cancer 0.428942 good example 0.428021 non-smoker 0.407426 care staff 0.426607 nicotine affect 0.427281 babysitters 0.406286 body 0.411562 smoker 0.414092 children 0.431937 harms 0.407652 sure caretakers 0.428123 secondhand smoke 0.971613 non-smokers 0.43912 heart disease‚ 0.429635 Fact 0.410452 short time 0.429909 somebody 0.406088 health problems 0.428728 smokefree restaurants 0.432863 lung infections 0.428228 smoking indoors 0.445671 main way smoking 0.477206 Breathing problems 0.428866	indoor public places 0.450365 babies 0.424287 smokers 0.419121 air 0.417572 life 0.412446 Breathing secondhand smoke 0.5983 infant death syndrome 0.453829 smoking 0.508887 National Cancer Institute 0.448359 heart attack‚ 0.429618 kids 0.411336 quiz 0.411311 cigarette 0.405834 coughing‚ extra phlegm‚ 0.454984 bronchitis 0.405901 people 0.432125 home 0.416331 nannies 0.405803 severe attacks 0.428972 best thing 0.428251 shortness 0.406847 ear infections 0.428442 low birth weight 0.454001 family 0.425482	CLICK HERE
3446	National Cancer Institute	Html	es	Consumo de cigarrillo: riesgos para la salud y cómo dejar de fumar (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre la investigación y pautas que se enfocan en la prevención y el abandono del tabaquismo.	efectos secundarios comentarios 0.501986 leucemia mieloide 0.427415 metabolitos carcinógenos 0.42791 bupropión marca dosis 0.454219 grupo vareniclina 0.463468 importancia clínica 0.450606 MVL Nicorette DS 0.439222 pruebas directas 0.619014 MVL Nicoderm CQ 0.440426 MVL Commit 0.42718 Sin embargo 0.467903 muertes prematuras 0.469229 largo plazo 0.764238 cessation interventions among 0.449671 Lung Health Study 0.44169 Lancaster T 0.545862 defunciones prematuras 0.434559 bupropión mejora 0.45245 Stead LF 0.482703 orientación mejora 0.429664 bupropión ap 0.446903 Nicotine replacement therapy 0.444158 semanas insomnio 0.443481 vareniclina mejora 0.477582 Estados Unidos 0.989049	polacrilex marca dosis 0.434801 insomnio riesgo 0.427937 smoking cessation 0.872626 salud pública 0.590985 Database Syst Rev 0.689429 abandono gradual versus 0.477395 nicotina marca dosis 0.473496 beneficio hipotético implícito 0.443214 Treating Tobacco Use 0.44172 versus trn 0.451335 MVL Nicorette 0.462807 mejores tasas 0.435725 Community Intervention Trial 0.530278 Marca Dosis Efectos 0.591077 alta calidad 0.516955 efectos secundarios advertencias 0.436485 compuestos carcinógenos 0.426773 tasas promedio 0.433836 aductos carcinógenos 0.42846 planta cytisus laburnum 0.434664 antidepresivo bupropión 0.449342 cuello uterino 0.576293 MVL Nicotrol 0.425887 Surveillance Modeling Network 0.440037	CLICK HERE
3573	National Cancer Institute	Html	en	Immunotherapy: Using the Immune System to Treat Cancer	Immunotherapies are treatments that restore or enhance the immune system’s natural ability to fight cancer. In just the past few years, the rapidly advancing field of cancer immunology has produced several new methods of treating cancer that increase the strength of immune responses against tumors.	abnormal cells 0.352853 CAR T cells 0.324531 cancer cells 0.817652 immune system activity 0.227645 immune responses 0.409806 toxic substance 0.204832 dendritic cells 0.272111 immune system molecules 0.223265 white blood cells 0.307219 activated T cells 0.296761 immune system—research 0.253725 immune response 0.250155 advanced lung cancer 0.212796 cancer treatment vaccine 0.201283 clinical trials 0.278634 tumor cells 0.49599 CD20-expressing cells 0.269956 normal cells 0.295119 human clinical trials 0.248944	antibody-dependent cell-mediated cytotoxicity 0.250246 patients 0.23385 advanced melanoma 0.22903 immune cells 0.680701 immune checkpoint inhibitors 0.313495 FDA-approved checkpoint inhibitors 0.216978 therapeutic antibodies 0.216622 cancer cell death 0.250231 immunotherapy uses proteins 0.212508 CAR T-cell therapy 0.397055 natural killer cells 0.304861 lymphoma cells 0.266327 cells 0.903811 different checkpoint protein 0.207351 modified T cells 0.282987 immune checkpoint proteins 0.3798 existing T cells 0.321978 certain immune cells 0.38886	CLICK HERE
16637	National Cancer Institute	Html	en	Metformin: Can a Diabetes Drug Help Prevent Cancer?	An article about the diabetes drug metformin, which research suggests may help prevent cancer.	metformin derivative 0.623089 cancer treatment 0.490275 study participants 0.484909 Dr. Heckman-Stoddard 0.535865 Family Comprehensive Cancer 0.513801 metformin arm 0.64832 early-phase prevention trials 0.505251 substantially lower risk 0.487063 original metformin formulation 0.653789 extensive laboratory research 0.487291 conventional antidiabetic doses 0.482196 Phase Prevention Trials 0.510585 clinical trials 0.598194 DPP Outcomes Study 0.570815 early-stage breast cancer 0.516459 laboratory studies 0.518492 Cancer Center 0.508828 Dr. Pollak 0.522365 triple-negative breast cancer 0.514736 postmenopausal breast cancer 0.520249 Dr. Zell 0.51558 cancer survivors 0.511148 Diego Moores Cancer 0.510708 metformin treatment 0.637604 large epidemiologic studies 0.500626	breast cancer cells 0.511965 cancer prevention 0.554231 primary cancer 0.48954 certain blood biomarkers 0.485052 cancer outcomes 0.485417 metformin derivatives 0.623142 blood biomarkers 0.487459 smaller prevention trials 0.498934 metformin 0.934872 breast cancer 0.751317 metformin’s effect 0.638135 cancer development 0.510096 early-stage clinical trials 0.564264 metformin’s impact 0.702491 breast cancer recurrences 0.517045 cancer clinical trials 0.527071 Diabetes Prevention Program 0.513336 cancer risk 0.512957 early-phase clinical trial 0.492505 cancer 0.791776 prevention trials 0.556708 diabetes drug metformin 0.743736 cancer incidence 0.513399 Antonio Breast Cancer 0.515009	CLICK HERE
16681	National Cancer Institute	Html	en	Cancer Moonshot℠ Blue Ribbon Panel Members	Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.	Walton Endowed Chair 0.567818 Cancer Genome Computational 0.597352 National Cancer Advisory 0.650925 cancer advocacy groups 0.631303 Integrative Cancer Research 0.659981 Cancer Disparities Program 0.610947 C. Zamecnik Chair 0.57469 Senior Vice President 0.528963 Harvard Medical School 0.539573 Chief Executive Officer 0.838453 Moores Cancer Center 0.633784 Cancer Center 0.989395 Principal Deputy Director 0.559096 Kimmel Cancer Center 0.636717 MGH Cancer Center 0.643509 Associate Professor 0.561481 Texas MD Anderson 0.619653 Scott Cancer Center 0.628322 Hopkins University School 0.586476 Lurie Comprehensive Cancer 0.604578 National Brain Tumor 0.535602 Alumni Distinguished Professor 0.55884 cancer health disparities 0.665713 Thomas Jefferson University 0.541957 cancer prevention 0.57231	Lineberger Comprehensive Cancer 0.60209 Huntsman Cancer Institute 0.643082 Ph.D 0.602332 Anderson Cancer Center 0.720144 Dana-Farber Cancer Institute 0.630726 Louisiana State University 0.545794 Pfizer Worldwide Research 0.555824 National Cancer Institute 0.714187 Cancer Research 0.712054 Sidney Kimmel 0.530896 Hospital Cancer Center 0.648303 Blue Ribbon Panel 0.726957 M.D 0.540388 Executive Vice President 0.545293 MD Anderson Cancer 0.692003 Ludwig Cancer Research 0.634757 Clinical Cancer Care 0.584227 Comprehensive Cancer Center 0.832766 Clausen Distinguished Professor 0.578861 Cancer Survivorship 0.543835 Kimmel Comprehensive Cancer 0.643464 Vanderbilt-Ingram Cancer Center 0.63051 University Feinberg School 0.566744 Deputy Director 0.630447	CLICK HERE
16775	National Cancer Institute	Html	es	Cancell/Cantron/Protocel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de Cancell/Entelev como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.429084 New Hampshire Avenue 0.419912 cabo ensayos 0.419001 Drug Administration 0.412413 NCI Best Case 0.439351 tipo cancell 0.440349 mejores pruebas 0.415762 datos bibliográficos pubmed 0.42161 siguientes preguntas 0.412513 James V 0.418429 National Cancer Institute 0.425345 siguientes riesgos 0.416342 seguro médico 0.411884 Instituto Nacional 0.685274 vitamina e 0.418575 Salud Complementaria 0.444832	Visuals Online 0.415001 complementarias revisa 0.421711 Physician Data Query 0.488672 nombre cancell 0.440323 Estados Unidos 0.994944 libre uso 0.416016 suficiente actividad 0.418205 siguientes sustancias 0.422749 página manejo 0.413947 ¿El tratamiento 0.424367 ¿Los beneficios 0.412704 juntos cam 0.411781 Series Program 0.412549 medicina complementaria 0.882014 Institutos Nacionales 0.47694	CLICK HERE